These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation. Frojmovic MM; Mooney RF; Wong T Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144 [TBL] [Abstract][Full Text] [Related]
43. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652 [TBL] [Abstract][Full Text] [Related]
44. Synergistic effect of peptide inhibitors derived from the extracellular and intracellular domain of α Gkourogianni AV; Kiouptsi K; Koloka V; Moussis V; Tsikaris V; Bachelot-Loza C; Tsoukatos DC Platelets; 2018 Jan; 29(1):34-40. PubMed ID: 28351192 [TBL] [Abstract][Full Text] [Related]
45. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease. Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330 [TBL] [Abstract][Full Text] [Related]
46. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets. Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990 [TBL] [Abstract][Full Text] [Related]
47. C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets. Skoglund C; Wetterö J; Tengvall P; Bengtsson T Immunobiology; 2010 Dec; 215(12):987-95. PubMed ID: 20163886 [TBL] [Abstract][Full Text] [Related]
48. Expression of surface platelet receptors (CD62P and CD41/61) in horses with recurrent airway obstruction (RAO). Iwaszko-Simonik A; Niedzwiedz A; Graczyk S; Slowikowska M; Pliszczak-Krol A Vet Immunol Immunopathol; 2015 Mar; 164(1-2):87-92. PubMed ID: 25665521 [TBL] [Abstract][Full Text] [Related]
49. Effect of advanced glycation end products on platelet activation and aggregation: a comparative study of the role of glyoxal and methylglyoxal. Arriagada-Petersen C; Fernandez P; Gomez M; Ravello N; Palomo I; Fuentes E; Ávila F Platelets; 2021 May; 32(4):507-515. PubMed ID: 32449466 [TBL] [Abstract][Full Text] [Related]
50. Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Hagberg IA; Lyberg T Platelets; 2000 May; 11(3):137-50. PubMed ID: 10938890 [TBL] [Abstract][Full Text] [Related]
51. [Role of adenosine diphosphate in the course of thrombin signal transmission]. Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817 [TBL] [Abstract][Full Text] [Related]
52. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Dardik R; Savion N; Kaufmann Y; Varon D Br J Cancer; 1998 Jun; 77(12):2069-75. PubMed ID: 9649116 [TBL] [Abstract][Full Text] [Related]
53. A fluorescence-conjugated immunobinding assay for the detection of P-selectin on platelets. Wen D; Nguyen TT; Plumhoff EA; Pineda AA; Bowie EJ; Kottke BA J Lab Clin Med; 1994 Sep; 124(3):447-54. PubMed ID: 7521896 [TBL] [Abstract][Full Text] [Related]
54. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis. Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki Y; Tomimatsu I; Ushida Y; Hosono F; Maeda K Nephron; 2002 Apr; 90(4):391-400. PubMed ID: 11961397 [TBL] [Abstract][Full Text] [Related]
55. Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents. Yamazaki M; Uchiyama S; Xiong Y; Nakano T; Nakamura T; Iwata M Thromb Res; 2005; 115(3):211-8. PubMed ID: 15617744 [TBL] [Abstract][Full Text] [Related]
56. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions. Granja T; Schad J; Schüssel P; Fischer C; Häberle H; Rosenberger P; Straub A Thromb Res; 2015 Oct; 136(4):786-96. PubMed ID: 26281714 [TBL] [Abstract][Full Text] [Related]
57. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease? Kälvegren H; Majeed M; Bengtsson T Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1677-83. PubMed ID: 12842841 [TBL] [Abstract][Full Text] [Related]
58. Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry? Kassassir H; Siewiera K; Sychowski R; Watała C Pharmacol Rep; 2013; 65(4):870-83. PubMed ID: 24145081 [TBL] [Abstract][Full Text] [Related]
59. Human neutrophil cathepsin G is a potent platelet activator. LaRosa CA; Rohrer MJ; Benoit SE; Rodino LJ; Barnard MR; Michelson AD J Vasc Surg; 1994 Feb; 19(2):306-18; discussion 318-9. PubMed ID: 7509416 [TBL] [Abstract][Full Text] [Related]
60. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes. Keating FK; Whitaker DA; Sobel BE; Schneider DJ Thromb Res; 2004; 113(1):27-34. PubMed ID: 15081562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]